Hasil Pencarian - Isabelle Bedrosian

  • Menampilkan 1 - 15 hasil dari 15
Perbaiki Hasil
  1. 1
    Gene signature associated with resistance to fluvastatin chemoprevention for breast cancer

    Gene signature associated with resistance to fluvastatin chemoprevention for breast cancer oleh Anjana Bhardwaj, Matthew D. Embury, Zhenlin Ju, Jing Wang, Isabelle Bedrosian

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer

    The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer oleh Anjana Bhardwaj, Harpreet Singh, Celestine Marie Trinidad, Constance T. Albarracin, Kelly K. Hunt, Isabelle Bedrosian

    Diterbitkan 2018-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Survival outcomes after omission of surgery for ductal carcinoma in situ

    Survival outcomes after omission of surgery for ductal carcinoma in situ oleh Elizabeth C. Poli, Wenli Dong, Simona F. Shaitelman, Nina Tamirisa, Yu Shen, Isabelle Bedrosian

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    The molecular heterogeneity of the precancerous breast affects drug efficacy

    The molecular heterogeneity of the precancerous breast affects drug efficacy oleh Anjana Bhardwaj, Raniv Dawey Rojo, Zhenlin Ju, Alexander Koh, Kazunoshin Tachibana, Jing Wang, Isabelle Bedrosian

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences

    Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences oleh Sukh Makhnoon, Angelica M. Gutierrez Barrera, Roland Bassett, Aimaz Afrough, Isabelle Bedrosian, Banu K. Arun

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling.

    Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling. oleh Anjana Bhardwaj, Nivetha Ganesan, Kazunoshin Tachibana, Kimal Rajapakshe, Constance T Albarracin, Preethi H Gunaratne, Cristian Coarfa, Isabelle Bedrosian

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Suppression of Akt-mTOR pathway-a novel component of oncogene induced DNA damage response barrier in breast tumorigenesis.

    Suppression of Akt-mTOR pathway-a novel component of oncogene induced DNA damage response barrier in breast tumorigenesis. oleh Anjana Bhardwaj, Daniel Rosen, Mei Liu, Yan Liu, Qiang Hao, Nivetha Ganesan, Carol J Etzel, Ashley Gullett, Constance T Albarracin, Isabelle Bedrosian

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Impact of Medicaid Expansion Under the Affordable Care Act on Receipt of Surgery for Breast Cancer

    Impact of Medicaid Expansion Under the Affordable Care Act on Receipt of Surgery for Breast Cancer oleh Leisha C. Elmore, MD, MPHS, Meng Li, ScM, PhD, Heather Lin, PhD, Yu Shen, PhD, Simona F. Shaitelman, MD, EdM, Gildy Babiera, MD, Nina Tamirisa, MD, Isabelle Bedrosian, MD

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation

    Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation oleh Marco Napoli, Xiaobo Li, Hayley D. Ackerman, Avani A. Deshpande, Ivan Barannikov, Marlese A. Pisegna, Isabelle Bedrosian, Jürgen Mitsch, Philip Quinlan, Alastair Thompson, Kimal Rajapakshe, Cristian Coarfa, Preethi H. Gunaratne, Douglas C. Marchion, Anthony M. Magliocco, Kenneth Y. Tsai, Elsa R. Flores

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer

    Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer oleh Brandon Mistretta, Sakuni Rankothgedera, Micah Castillo, Mitchell Rao, Kimberly Holloway, Anjana Bhardwaj, Maha El Noafal, Constance Albarracin, Randa El-Zein, Hengameh Rezaei, Xiaoping Su, Rehan Akbani, Xiaoshan M. Shao, Brian J. Czerniecki, Rachel Karchin, Isabelle Bedrosian, Preethi H. Gunaratne, Preethi H. Gunaratne, Preethi H. Gunaratne

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis

    Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis oleh Amy C. Moreno, MD, Yan Heather Lin, PhD, Isabelle Bedrosian, MD, Yu Shen, PhD, Michael C. Stauder, MD, Benjamin D. Smith, MD, Thomas A. Buchholz, MD, Gildy V. Babiera, MD, Wendy A. Woodward, MD, PhD, Simona F. Shaitelman, MD, EdM

    Diterbitkan 2017-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Effectiveness and Safety of Magseed Localization for Excision of Breast Lesions

    Effectiveness and Safety of Magseed Localization for Excision of Breast Lesions oleh Puneet Singh, MD, Marion E. Scoggins, MD, Aysegul A. Sahin, MD, Rosa F. Hwang, MD, Henry M. Kuerer, MD, PhD, Abigail S. Caudle, MD, Elizabeth A. Mittendorf, MD, PhD, Alastair M. Thompson, MBChB, MD, Isabelle Bedrosian, MD, Mediget Teshome, MD, Sarah M. DeSnyder, MD, Funda Meric-Bernstam, MD, Kelly K. Hunt, MD

    Diterbitkan 2020-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program

    Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered... oleh Anusha Gandhi, Tianlin Xu, Sarah M. DeSnyder, Grace L. Smith, Ruitao Lin, Carlos H. Barcenas, Michael C. Stauder, Karen E. Hoffman, Eric A. Strom, Susan Ferguson, Benjamin D. Smith, Wendy A. Woodward, George H. Perkins, Melissa P. Mitchell, Desmond Garner, Chelain R. Goodman, Melissa Aldrich, Marigold Travis, Susan Lilly, Isabelle Bedrosian, Simona F. Shaitelman

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.

    Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. oleh Priscilla F McAuliffe, Kurt W Evans, Argun Akcakanat, Ken Chen, Xiaofeng Zheng, Hao Zhao, Agda Karina Eterovic, Takafumi Sangai, Ashley M Holder, Chandeshwar Sharma, Huiqin Chen, Kim-Anh Do, Emily Tarco, Mihai Gagea, Katherine A Naff, Aysegul Sahin, Asha S Multani, Dalliah M Black, Elizabeth A Mittendorf, Isabelle Bedrosian, Gordon B Mills, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.

    Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. oleh Priscilla F McAuliffe, Kurt W Evans, Argun Akcakanat, Ken Chen, Xiaofeng Zheng, Hao Zhao, Agda Karina Eterovic, Takafumi Sangai, Ashley M Holder, Chandeshwar Sharma, Huiqin Chen, Kim-Anh Do, Emily Tarco, Mihai Gagea, Katherine A Naff, Aysegul Sahin, Asha S Multani, Dalliah M Black, Elizabeth A Mittendorf, Isabelle Bedrosian, Gordon B Mills, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: